Drug Profile
QM 96521
Alternative Names: EA 521Latest Information Update: 11 Jun 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source; Nonindustrial sources
- Class Antivirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 11 Jun 2001 No-Development-Reported for HIV-1 infections in Belgium (Unknown route)
- 11 Jun 2001 No-Development-Reported for HIV-1 infections in Spain (Unknown route)
- 29 Sep 1998 New profile